Combined effects of a thymic peptide, thymopoietin and myasthenic patient sera in rat myotube culture
- PMID: 1343090
- DOI: 10.1016/0022-510x(92)90154-d
Combined effects of a thymic peptide, thymopoietin and myasthenic patient sera in rat myotube culture
Retraction in
-
Retraction.J Neurol Sci. 1993 Dec 1;120(1):120. doi: 10.1016/0022-510x(93)90036-x. J Neurol Sci. 1993. PMID: 8289074 No abstract available.
Abstract
We investigated in a rat myotube assay the combined effect of 26 myasthenic (MG) patient sera and a thymic peptide, thymopoietin (Tpo) which had previously been shown to bind Torpedo and human AChR and to compete with alpha-bungarotoxin (alpha-Bgt) binding. Cultures were first exposed to Tpo alone for 3 h (0.3, 7.5, 15 nM), then MG sera (5% final dilution) were added for an additional 18 h. Reduction in the amount of 125I-alpha-Bgt binding sites in the presence of various concentrations of Tpo were similar with control sera and in all the patients with low or undetectable anti-AChR Ab (11 cases). In cultures exposed to Tpo and sera with high anti-AChR Ab titre (15 cases), Tpo and anti-AChR Ab have an additive capacity to reduce the number of alpha-Bgt binding sites. The results are compatible with the hypothesis that anti-AChR Ab and Tpo could impair neuromuscular transmission by complementary mechanisms.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
